GlassScriptPhysician profile
Carolina Rocha
NPI 1457946493
$5,047.68
in general payments reported to CMS, 2019-2025
24 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,428 · 2023: $819 · 2024: $1,226 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,593 · Travel and Lodging: $26.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,592.98 |
| Travel and Lodging | $26.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $969.45 | 2022-2025 | Watchman Flx, Watchman, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $879.04 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $694.26 | 2022-2025 | Leqvio |
| Amgen INC. | $457.23 | 2022-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $433.81 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $316.05 | 2022-2024 | Xarelto |
| Atricure, INC. | $297.18 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryoablation System (Cryo2) |
| Abbott Laboratories | $144.31 | 2024 | Cardiomems |
| Pfizer INC. | $139.67 | 2022 | |
| Edwards Lifesciences Corporation | $117.19 | 2025 | |
| Alnylam Pharmaceuticals INC. | $106.89 | 2023-2025 | Onpattro |
| Bridgebio Pharma, INC. | $72.88 | 2025 | Attruby |
| Novo Nordisk INC | $71.31 | 2022-2023 | Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $65.78 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $40.77 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $39.86 | 2022 | |
| Chiesi USA, INC. | $34.51 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $31.38 | 2023 | Arcalyst |
| Medtronic, INC. | $26.52 | 2025 | Azure Xt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals LP | $24.71 | 2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.17 | 2022 | |
| Heartflow, INC. | $21.88 | 2025 | |
| Terumo Medical Corporation | $19.99 | 2022 | |
| Lilly USA, LLC | $18.84 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolina Rocha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.